Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis.
Gerd-Rüdiger R BurmesterKenneth B GordonJames T RosenbaumDilek ArikanWinnie L LauPeigang LiFreddy FaccinRemo PanaccionePublished in: Advances in therapy (2019)
The safety profile of adalimumab was consistent with previous findings and no new safety signals were observed.